DrugMapper
Browse
Therapeutic Area
CANCER (51)
CARDIOVASCULAR (45)
DENTISTRY (2)
DERMATOLOGY (31)
DIABETES DRUGS & ENDOCRINOLOGY (61)
EMERGENCY MEDICINE (3)
ENT (5)
EYE (23)
GASTROINTESTINAL (29)
HEMATOLOGY (23)
MUSCULOSKELETAL (28)
NEUROLOGY DRUGS & NERVOUS SYSTEM (50)
PEDIATRICS (27)
PHARMACOLOGY (8)
PREGNANCY AND GYNECOLOGY (30)
RESPIRATORY (42)
RHEUMATOLOGY (19)
OTHER (1482)
Therapeutic Indication
Adverse Reaction (System Organ Classification)
Mechanism of Action
Primary Target
Target Level
Level 1
Level 2
Level 3
Level 4
Level 5
Level 6
Active Pharmaceutical Ingredients (APIs)
Small Molecules
ProDrugs
Antibodies
CNS drugs
Metabolites
Search
Therapeutic Indication
Adverse Reaction (System Organ Classification)
Mechanism of Action
Target Sequence
Chemical Structure
Physicochemical Properties
Analyze
Networks
Chemical Similarity
Scaffold Similarity
KNIME workflow
Downloads
Web services
Bulk Downloads
About
DrugMapper FAQs
Data Sources
Contact Us
Display Options:
Drug type
Therapeutic Area
Route of administration
Mechanism of Action
Indication
Status
Total:
6532
TELRATOLIMOD
1
Small molecule
Investigational
Unknown
Unknown
HIV Infections; Lymphoma, T-Cell, Cutaneous
Toll-like receptor 7 agonist
TELRATOLIMOD
×
Maximum Phase:
1
First Approval:
None
UNII:
16598XQ2BT
Molecule Type:
Small molecule
Molecular Formula:
C36H59N5O2
Molecular Weight:
593.9
AlogP:
9.1
PSA:
95.06
HBD:
2.0
HBA:
#RotB:
25.0
Source:
AZD-5153
1
Small molecule
Investigational
Unknown
Unknown
Leukemia, Myeloid, Acute; Lymphoma, Large B-Cell, Diffuse
Unknown
AZD-5153
×
Maximum Phase:
1
First Approval:
None
UNII:
C7C7U6YEAO
Molecule Type:
Small molecule
Molecular Formula:
C25H33N7O3
Molecular Weight:
479.59
AlogP:
2.06
PSA:
88.33
HBD:
0.0
HBA:
#RotB:
7.0
Source:
KL-1333
1
Small molecule
Investigational
Unknown
Unknown
MELAS Syndrome; Mitochondrial Diseases
Unknown
KL-1333
×
Maximum Phase:
1
First Approval:
None
UNII:
NA2ZOL5UGM
Molecule Type:
Small molecule
Molecular Formula:
C14H12N2O2
Molecular Weight:
240.26
AlogP:
2.58
PSA:
62.82
HBD:
1.0
HBA:
#RotB:
1.0
Source:
SRX251
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Vasopressin V1a receptor antagonist
SRX251
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
CROLIBULIN
1
Small molecule
Investigational
Unknown
Unknown
Neoplasms; Thyroid Neoplasms
Tubulin inhibitor
CROLIBULIN
×
Maximum Phase:
1
First Approval:
None
UNII:
9ENT43KY91
Molecule Type:
Small molecule
Molecular Formula:
C18H17BrN4O3
Molecular Weight:
417.26
AlogP:
2.85
PSA:
129.54
HBD:
3.0
HBA:
#RotB:
3.0
Source:
PROPYL GALLATE
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
PROPYL GALLATE
×
Maximum Phase:
1
First Approval:
None
UNII:
8D4SNN7V92
Molecule Type:
Small molecule
Molecular Formula:
C10H12O5
Molecular Weight:
212.2
AlogP:
1.37
PSA:
86.99
HBD:
3.0
HBA:
#RotB:
3.0
Source:
DS-3078A
1
Small molecule
Investigational
Unknown
Unknown
Lymphoma
Serine/threonine-protein kinase mTOR inhibitor
DS-3078A
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
ILX23-7553
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Vitamin D receptor agonist
ILX23-7553
×
Maximum Phase:
1
First Approval:
None
UNII:
O13QTC8612
Molecule Type:
Small molecule
Molecular Formula:
C27H38O3
Molecular Weight:
410.6
AlogP:
4.85
PSA:
60.69
HBD:
3.0
HBA:
#RotB:
3.0
Source:
AZD-7687
1
Small molecule
Investigational
Unknown
Unknown
Obesity
Unknown
AZD-7687
×
Maximum Phase:
1
First Approval:
None
UNII:
6QTJ9P2NYT
Molecule Type:
Small molecule
Molecular Formula:
C21H25N3O3
Molecular Weight:
367.45
AlogP:
3.61
PSA:
106.17
HBD:
2.0
HBA:
#RotB:
5.0
Source:
GSK159802
1
Small molecule
Investigational
Unknown
Unknown
Pulmonary Disease, Chronic Obstructive
Beta-2 adrenergic receptor agonist
GSK159802
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
LY-2584702
1
Small molecule
Investigational
Unknown
Unknown
Carcinoma, Non-Small-Cell Lung; Carcinoma, Renal Cell; Neoplasm Metastasis; Neoplasms; Neuroendocrine Tumors
Ribosomal protein S6 kinase 1 inhibitor
LY-2584702
×
Maximum Phase:
1
First Approval:
None
UNII:
I4965C6W4O
Molecule Type:
Small molecule
Molecular Formula:
C21H19F4N7
Molecular Weight:
445.42
AlogP:
4.3
PSA:
75.52
HBD:
1.0
HBA:
#RotB:
3.0
Source:
AV-412
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
AV-412
×
Maximum Phase:
1
First Approval:
None
UNII:
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
MIV-818
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
MIV-818
×
Maximum Phase:
1
First Approval:
None
UNII:
Q1I6YZ0NGF
Molecule Type:
Small molecule
Molecular Formula:
C22H30BrN4O8P
Molecular Weight:
589.38
AlogP:
3.37
PSA:
153.23
HBD:
2.0
HBA:
#RotB:
12.0
Source:
RG7893
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Sodium channel protein type IX alpha subunit blocker
RG7893
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
LISAVANBULIN
1
Small molecule
Investigational
Unknown
Unknown
Glioblastoma; Neoplasms
Unknown
LISAVANBULIN
×
Maximum Phase:
1
First Approval:
None
UNII:
5PT0QP06X5
Molecule Type:
Small molecule
Molecular Formula:
C26H29N9O3
Molecular Weight:
515.58
AlogP:
2.69
PSA:
190.77
HBD:
4.0
HBA:
#RotB:
13.0
Source:
VLX-1005
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
VLX-1005
×
Maximum Phase:
1
First Approval:
None
UNII:
JKU4XCC48Y
Molecule Type:
Small molecule
Molecular Formula:
C21H19N3O4S2
Molecular Weight:
441.53
AlogP:
4.42
PSA:
100.55
HBD:
3.0
HBA:
#RotB:
7.0
Source:
DANIQUIDONE
1
Small molecule
Investigational
Unknown
Unknown
Neoplasms
Unknown
DANIQUIDONE
×
Maximum Phase:
1
First Approval:
None
UNII:
E780TX33D2
Molecule Type:
Small molecule
Molecular Formula:
C15H11N3O
Molecular Weight:
249.27
AlogP:
2.32
PSA:
58.69
HBD:
1.0
HBA:
#RotB:
0.0
Source:
XL-844
1
Small molecule
Investigational
Unknown
Unknown
Leukemia, Lymphocytic, Chronic, B-Cell; Lymphoma; Neoplasms
Serine/threonine-protein kinase Chk1 inhibitor
XL-844
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
TAK-960
1
Small molecule
Investigational
Unknown
Unknown
Neoplasms
Serine/threonine-protein kinase PLK1 inhibitor
TAK-960
×
Maximum Phase:
1
First Approval:
None
UNII:
3831VFM1ZB
Molecule Type:
Small molecule
Molecular Formula:
C27H34F3N7O3
Molecular Weight:
561.61
AlogP:
3.55
PSA:
102.93
HBD:
2.0
HBA:
#RotB:
6.0
Source:
ROCACETRAPIB
1
Small molecule
Investigational
Unknown
Unknown
Lipid Metabolism Disorders
Cholesteryl ester transfer protein inhibitor
ROCACETRAPIB
×
Maximum Phase:
1
First Approval:
None
UNII:
K9SP3L3YQP
Molecule Type:
Small molecule
Molecular Formula:
C31H34F7NO3
Molecular Weight:
601.6
AlogP:
9.54
PSA:
38.77
HBD:
0.0
HBA:
#RotB:
6.0
Source:
SGX-523
1
Small molecule
Investigational
Unknown
Unknown
Neoplasms
Hepatocyte growth factor receptor inhibitor
SGX-523
×
Maximum Phase:
1
First Approval:
None
UNII:
WH8SQN09KJ
Molecule Type:
Small molecule
Molecular Formula:
C18H13N7S
Molecular Weight:
359.42
AlogP:
3.22
PSA:
73.79
HBD:
0.0
HBA:
#RotB:
3.0
Source:
RODATRISTAT ETHYL
1
Small molecule
Investigational
Unknown
Unknown
Hypertension, Pulmonary
Tryptophan 5-hydroxylase 1 inhibitor
RODATRISTAT ETHYL
×
Maximum Phase:
1
First Approval:
None
UNII:
507FY6OL37
Molecule Type:
Small molecule
Molecular Formula:
C29H31ClF3N5O3
Molecular Weight:
590.05
AlogP:
5.57
PSA:
102.6
HBD:
2.0
HBA:
#RotB:
7.0
Source:
MK-6592
1
Small molecule
Investigational
Unknown
Unknown
Neoplasms
Serine/threonine-protein kinase Aurora inhibitor
MK-6592
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
C25H26ClF2N7O2
Molecular Weight:
529.98
AlogP:
4.28
PSA:
99.27
HBD:
2.0
HBA:
#RotB:
7.0
Source:
N6022
1
Small molecule
Investigational
Unknown
Unknown
Asthma; Cystic Fibrosis
Alcohol dehydrogenase class III inhibitor
N6022
×
Maximum Phase:
1
First Approval:
None
UNII:
80LIU5P95D
Molecule Type:
Small molecule
Molecular Formula:
C24H22N4O3
Molecular Weight:
414.47
AlogP:
3.75
PSA:
103.14
HBD:
2.0
HBA:
#RotB:
7.0
Source:
ZOTATIFIN
1
Small molecule
Investigational
Unknown
Unknown
Neoplasms; Severe Acute Respiratory Syndrome
Unknown
ZOTATIFIN
×
Maximum Phase:
1
First Approval:
None
UNII:
2EWN8Z05CN
Molecule Type:
Small molecule
Molecular Formula:
C28H29N3O5
Molecular Weight:
487.56
AlogP:
2.78
PSA:
108.07
HBD:
2.0
HBA:
#RotB:
6.0
Source:
8-CHLOROADENOSINE
1
Small molecule
Investigational
Unknown
Unknown
Leukemia, Myeloid, Acute
Unknown
8-CHLOROADENOSINE
×
Maximum Phase:
1
First Approval:
None
UNII:
PA05MFH3I7
Molecule Type:
Small molecule
Molecular Formula:
C10H12ClN5O4
Molecular Weight:
301.69
AlogP:
-1.33
PSA:
139.54
HBD:
4.0
HBA:
#RotB:
2.0
Source:
HYDROXYNORKETAMINE, (2R,6R)-, HYDROCHLORIDE
1
Small molecule
Investigational
Unknown
Unknown
Depressive Disorder, Major
Unknown
HYDROXYNORKETAMINE, (2R,6R)-, HYDROCHLORIDE
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
C12H15Cl2NO2
Molecular Weight:
276.16
AlogP:
1.61
PSA:
63.32
HBD:
2.0
HBA:
#RotB:
1.0
Source:
SGI-1776
1
Small molecule
Investigational
Unknown
Unknown
Leukemia; Lymphoma, Non-Hodgkin; Prostatic Neoplasms, Castration-Resistant
Serine/threonine-protein kinase PIM inhibitor
SGI-1776
×
Maximum Phase:
1
First Approval:
None
UNII:
72AUA0603W
Molecule Type:
Small molecule
Molecular Formula:
C20H22F3N5O
Molecular Weight:
405.42
AlogP:
4.05
PSA:
54.69
HBD:
1.0
HBA:
#RotB:
5.0
Source:
BIIF 1149 BS
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
BIIF 1149 BS
×
Maximum Phase:
1
First Approval:
None
UNII:
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
AZD-7762
1
Small molecule
Investigational
Unknown
Unknown
Neoplasms
Serine/threonine-protein kinase Chk1 inhibitor
AZD-7762
×
Maximum Phase:
1
First Approval:
None
UNII:
5D822Y3L1H
Molecule Type:
Small molecule
Molecular Formula:
C17H19FN4O2S
Molecular Weight:
362.43
AlogP:
2.53
PSA:
96.25
HBD:
4.0
HBA:
#RotB:
4.0
Source:
BLI-489
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
BLI-489
×
Maximum Phase:
1
First Approval:
None
UNII:
R56JYB8P8Z
Molecule Type:
Small molecule
Molecular Formula:
C13H11N3O4S
Molecular Weight:
305.31
AlogP:
0.64
PSA:
84.66
HBD:
1.0
HBA:
#RotB:
2.0
Source:
FEDOVAPAGON
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
FEDOVAPAGON
×
Maximum Phase:
1
First Approval:
None
UNII:
VX2GBO4I0V
Molecule Type:
Small molecule
Molecular Formula:
C27H34N4O3
Molecular Weight:
462.59
AlogP:
3.74
PSA:
72.96
HBD:
1.0
HBA:
#RotB:
4.0
Source:
AZD-1208
1
Small molecule
Investigational
Unknown
Unknown
Leukemia, Myeloid, Acute; Lymphoma; Neoplasms
Serine/threonine-protein kinase PIM inhibitor
AZD-1208
×
Maximum Phase:
1
First Approval:
None
UNII:
S98NFM1378
Molecule Type:
Small molecule
Molecular Formula:
C21H21N3O2S
Molecular Weight:
379.49
AlogP:
3.61
PSA:
75.43
HBD:
2.0
HBA:
#RotB:
3.0
Source:
KX2-361
1
Small molecule
Investigational
Unknown
Unknown
Neoplasms
Unknown
KX2-361
×
Maximum Phase:
1
First Approval:
None
UNII:
RVW387BA9U
Molecule Type:
Small molecule
Molecular Formula:
C24H24FN3O2
Molecular Weight:
405.47
AlogP:
3.58
PSA:
54.46
HBD:
1.0
HBA:
#RotB:
6.0
Source:
CROBENETINE
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
CROBENETINE
×
Maximum Phase:
1
First Approval:
None
UNII:
Q72DWI2G4C
Molecule Type:
Small molecule
Molecular Formula:
C25H33NO2
Molecular Weight:
379.54
AlogP:
4.91
PSA:
32.7
HBD:
1.0
HBA:
#RotB:
5.0
Source:
1
2
…
60
61
62
63
64
65
66
…
186
187
Next »
Download Option
Close
Header
Compound Name
Maximum Phase
Compound Structure
Smile
Inchi
InchiKey
Compound Properties
Molecular Formula
Molecular Weight
ALogP
PSA